Which scan is better for spotting brain tumors? tiny study aims to find out

NCT ID NCT04298541

Not yet recruiting Diagnosis Sponsor: Weill Medical College of Cornell University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will compare two types of PET scans (using different radioactive tracers) in 6 adults with suspected meningioma who are scheduled for surgery. Each person will get both scans at least 24 hours apart. The goal is to see which tracer gives clearer images of the tumor, which could help doctors better diagnose and plan treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ga-68-DOTATATE and Ga-68-DOTATOC (radioactive tracers for PET scans)
What this could lead to: If successful, this could help determine which tracer is better for detecting meningioma, potentially improving diagnosis and treatment planning.
What could go wrong: This is a very small, early-phase study with only 6 participants, so results may not apply to everyone. It focuses on imaging comparison, not treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

meningioma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MENINGIOMA

Contacts and locations

Locations

Weill Cornell Medical College of Cornell University

New York, New York, 10021, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.